Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Genome-wide analysis of rapamycin effect on the glucocorticoid receptor function in human keratinocytes

ABSTRACT: Rapamycin increased negative effect of glucocorticoid fluocinolone acetonide (FA) on gene expression and blunted gene activation by glucocorticoid FA.

ORGANISM(S): Homo sapiens

PROVIDER: GSE97279 | GEO | 2017/04/01

SECONDARY ACCESSION(S): PRJNA381191

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Genome-wide analysis of LY294002 effect on the glucocorticoid receptor function in human keratinocytes

Project description:LY294002 increased negative effect of glucocorticoid fluocinolone acetonide (FA) on gene expression and blunted activation of some GR-target genes by glucocorticoid FA.

2019-01-01 | GSE120991 | GEO

Analaysis of global effect of the glucocorticoid fluocinolone acetonide on gene expression in human REDD1 KO HaCaT keratinocytes in comparison to Cas9 HaCaT cells

Project description:REDD1 is required for full amplitude activation of the glucocorticoid receptor. In keratinocytes lacking REDD1 both gene activation and repression by glucocorticoid fluocinolone acetonide was significantly blunted.

2022-07-23 | GSE209519 | GEO

Effect of glucocorticoid chemical structure and receptor potency on human trabecular meshwork cells

Project description:Glucocorticoids with different chemical structures but similar glucocorticoid receptor potency regulate subsets of common and unique genes in human trabecular meshwork cells. Gene expression changes of human trabecular meshwork cells, TM 86 and TM 93, due to treatment with dexamethasone (Dex), fluocinolone acetonide (FA), and triamcinolone acetonide (TA).

2010-02-15 | GSE16643 | GEO

Sexual dimorphism in transcriptomic response to fluocinolone acetonide (FA) in murine epidermis

Project description:Topical application of glucocorticoid fluocinolone acetonide (FA) induces sexually dimorphic transcriptomic response in murine epidermis NULL

2020-01-01 | GSE131131 | GEO

Identification of rapamycin as a glucocorticoid resistance reversal agent

Project description:Drug resistance remains a major obstacle to successful cancer treatment. Here we use a novel approach to identify rapamycin as a glucocorticoid resistance reversal agent. A database of drug-associated gene expression profiles was screened for molecules whose profile overlapped with a gene expression signature of glucocorticoid (GC) sensitivity/resistance in Acute Lymphoblastic Leukemia (ALL) cells. The screen indicated the mTOR inhibitor rapamycin profile matched the signature of GC-sensitivity. We thus tested the hypothesis that rapamycin would induce GC sensitivity in lymphoid malignancy cells, and found that it sensitized cells to glucocorticoid induced apoptosis via modulation of antiapoptotic MCL1. These data indicate that MCL1 is an important regulator of GC-induced apoptosis, and that the combination of rapamycin and glucocorticoids has potential utility in ALL. Furthermore this approach represents a novel strategy for identification of promising combination therapies for cancer. This SuperSeries is composed of the SubSeries listed below.

2006-09-14 | GSE5824 | GEO